PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement (PROTECTED TAVR)

October 13, 2022 updated by: Boston Scientific Corporation

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter

To demonstrate that use of the Sentinel® Cerebral Protection System significantly reduces the risk of peri-procedural stroke (≤72 hours) after transcatheter aortic valve replacement (TAVR).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

3000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Australia
      • Chermside, Australia, 4032
        • The Prince Charles Hospital
    • Victoria
      • Clayton, Victoria, Australia, 3168
        • Monash Medical Center
  • Denmark
      • Aarhus, Denmark, 8200
        • Aarhus University Hospital
      • Aarhus, Denmark, DK-8200
        • Aarhus University Hospital
      • København, Denmark, 2100
        • Rigshospitalet
  • France
      • Marseille, France, 13005
        • CHU La Timone Hospital
      • Toulouse, France, 31076
        • Clinique Pasteur
  • Germany
      • Bad Segeberg, Germany, 23795
        • Heart Center Leipzig
      • Dresden, Germany, D-01307
        • Herzzentrum Dresden GmbH
      • Frankfurt, Germany, 60590
        • University Hospital Frankfurt
      • Lübeck, Germany, D-23538
        • Universitaetsklinikum Schleswig-Holstein
      • Münich, Germany, 81377
        • LMU Klinikum der Universität München
      • Ulm, Germany, 89081
        • Universitaetsklinikum Ulm
  • Italy
      • Cotignola, Italy, 48010
        • Maria Cecilia Hospital SPA
      • Milan, Italy, 20132
        • Fondazione Centro San Raffaele
    • Milanese
      • San Donato, Milanese, Italy, 20097
        • Policlínico San Donato
  • United States
    • Arizona
      • Tucson, Arizona, United States, 85712
        • Tucson Medical Center
    • California
      • Los Angeles, California, United States, 90048
        • Cedars Sinai Medical Center
      • Sacramento, California, United States, 95817
        • University of California, Davis Medical Center
      • San Francisco, California, United States, 94118
        • Kaiser Foundation Hospital - San Francisco
      • Thousand Oaks, California, United States, 91360
        • Los Robles Regional Medical Center
    • Colorado
      • Littleton, Colorado, United States, 80120
        • South Denver Cardiology Associates PC and Swedish medical center
    • Connecticut
      • Hartford, Connecticut, United States, 06102
        • Hartford Hospital
    • District of Columbia
      • Washington, District of Columbia, United States, 20010
        • MedStar Washington Hospital Center
    • Florida
      • Sarasota, Florida, United States, 34239
        • Intercoastal Medical Group
      • Tampa, Florida, United States, 33606
        • Tampa General Hospital
    • Georgia
      • Atlanta, Georgia, United States, 30309
        • Piedmont Hosptial
      • Marietta, Georgia, United States, 30060
        • Wellstar
    • Illinois
      • Springfield, Illinois, United States, 62701
        • St. Johns Hospital
    • Indiana
      • Munster, Indiana, United States, 46321
        • Community Munster
    • Iowa
      • Des Moines, Iowa, United States, 50314
        • Mercy Hospital Medical Center
      • Iowa City, Iowa, United States, 52242
        • University of Iowa Hospitals and Clinics
    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Massachusetts General Hospital
      • Burlington, Massachusetts, United States, 01805
        • Lahey Clinic Hospital
    • Michigan
      • Lansing, Michigan, United States, 48912
        • Sparrow Hospital
    • Minnesota
      • Minneapolis, Minnesota, United States, 55407
        • Abbott Northwestern Hospital
    • Missouri
      • Kansas City, Missouri, United States, 64132
        • Research Medical Center
    • Nebraska
      • Omaha, Nebraska, United States, 68124
        • Creighton - Bergan Cardiology
    • New Jersey
      • Englewood, New Jersey, United States, 07631
        • Englewood Medical Center
      • Neptune, New Jersey, United States, 98374
        • Jersey Shore University Medical Center
    • New York
      • Buffalo, New York, United States, 14213
        • Kaleida Health
      • Manhasset, New York, United States, 11030
        • North Shore University Hospital
      • Mineola, New York, United States, 11501
        • NYU Winthrop
    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest University School of Medicine
    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic Foundation
    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health Sciences University
    • Pennsylvania
      • Wynnewood, Pennsylvania, United States, 19096
        • Lankenau
    • Tennessee
      • Memphis, Tennessee, United States, 38120
        • Baptist Memorial
      • Nashville, Tennessee, United States, 37203
        • Centennial Medical Center
      • Nashville, Tennessee, United States, 37323
        • Vanderbilt
    • Texas
      • Austin, Texas, United States, 78705
        • Heart Hospital of Austin
      • Dallas, Texas, United States, 75226
        • Baylor Heart and Vascular
      • Houston, Texas, United States, 77030
        • The Methodist Hospital
      • Plano, Texas, United States, 75093
        • The Heart Hospital Baylor Plano
      • Round Rock, Texas, United States, 78665
        • Baylor Scott and White
      • San Antonio, Texas, United States, 78229
        • Methodist Healthcare System of San Antonio dba Methodist Hospital
    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53215
        • Aurora St. Luke's Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject has documented aortic valve stenosis and is treated with an approved TAVR device via transfemoral access
  • Subject has the recommended artery diameter at the site of filter placement per the Sentinel® Cerebral Protection System Instructions For Use: 9-15 mm for the brachiocephalic artery and 6.5-10 mm in the left common carotid artery.
  • Subject (or legal representative) provides written informed consent.

Exclusion Criteria:

  • Subject has arterial stenosis >70% in either the left common carotid artery or the brachiocephalic artery.
  • Subject's brachiocephalic or left carotid artery reveals significant stenosis, ectasia, dissection, or aneurysm at the aortic ostium or within 3 cm of the aortic ostium.
  • Subject has compromised blood flow to the right upper extremity.
  • Subject has access vessels with excessive tortuosity.
  • Subject has uncorrected bleeding disorders.
  • Subject is contraindicated for anticoagulant and antiplatelet therapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TAVR with Sentinel
Patients assigned to this group will undergo TAVR with the Sentinel® Cerebral Protection System.
Device: Sentinel® Cerebral Protection System
cerebral embolic protection system
No Intervention: TAVR without Sentinel
Patients assigned to this group will undergo TAVR without the Sentinel® Cerebral Protection System.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of stroke through 72 hours post TAVR procedure or discharge (whichever comes first)
Time Frame: <=72 hours
All stroke (hemorrhagic, ischemic, or undetermined status; disabling or nondisabling) through 72 hours post TAVR procedure or discharge (whichever comes first), as adjudicated by an independent Clinical Events Committee (CEC) and using Neurologic Academic Research Consortium (NeuroARC) definitions.
<=72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Boston Scientific Corporation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 7, 2020

Primary Completion (Actual)

February 1, 2022

Study Completion (Actual)

February 1, 2022

Study Registration Dates

First Submitted

October 31, 2019

First Submitted That Met QC Criteria

October 31, 2019

First Posted (Actual)

November 4, 2019

Study Record Updates

Last Update Posted (Actual)

October 14, 2022

Last Update Submitted That Met QC Criteria

October 13, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • S2453

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

The data and study protocol for this clinical trial may be made available to other researchers in accordance with the Boston Scientific Data Sharing Policy (http://www.bostonscientific.com/en-US/data-sharing-requests.html)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Sentinel® Cerebral Protection System

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe